{"id":359,"date":"2014-04-07T07:09:31","date_gmt":"2014-04-07T07:09:31","guid":{"rendered":"https:\/\/blogs.bmj.com\/jnnp\/?p=359"},"modified":"2014-04-07T07:09:31","modified_gmt":"2014-04-07T07:09:31","slug":"factors-governing-progression-in-ms-something-old-something-frequent","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/jnnp\/2014\/04\/07\/factors-governing-progression-in-ms-something-old-something-frequent\/","title":{"rendered":"Factors governing progression in MS:  Something old, something frequent!"},"content":{"rendered":"<p>The holy grail of MS therpay is to prevent the onset of the debilitating MS phase.\u00a0 All of the current therpaies are aimed at preventing such developments, and more importantly early treatment with immunomodulatory therapies was shown to be more efficacious at preventing disability development.\u00a0\u00a0 The issue of whether multiple relapses or &#8220;attacks&#8221; govern diability development has been one of active research, and certainly all therapeutic trial assess the anualised relapse rates.<\/p>\n<p>In the January issue of JNNP, Scalfari and colleagues assess the the factors that govern development of secondary progressive MS.\u00a0 Importantly, a higher annualised relpase rate (increased relapse frequency), older age at disease onset and male sex all predict diasbility development in MS.\u00a0 Clealry, the only modifiable factor is the relapse rate and consequently, early therpy does seem to make sense.\u00a0 It would be interesting tokow whether &#8220;non-clinical&#8221; biomakers, say peratining to lesion load or neurophysiological parameters could further stratify risk for progresison in MS.<\/p>\n<p>&nbsp;<\/p>\n<p>Let me know your thoughts?\u00a0 Read more at http:\/\/jnnp.bmj.com\/content\/85\/1\/67.abstract<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<h1 id=\"article-title-1\">Onset of secondary progressive phase and long-term evolution of multiple sclerosis<\/h1>\n<p><span class=\"custom-flag patients-choice\"><img loading=\"lazy\" decoding=\"async\" title=\"Patient's Choice\" alt=\"Patient's Choice\" src=\"http:\/\/jnnp.bmj.com\/publisher\/icons\/toc\/pc-cyan.gif\" width=\"75\" height=\"20\" \/><\/span><\/p>\n<ol class=\"contributor-list\" id=\"contrib-group-1\">\n<li class=\"contributor\" id=\"contrib-1\"><span class=\"name\"><a class=\"name-search\" href=\"http:\/\/jnnp.bmj.com\/search?author1=Antonio+Scalfari&amp;sortspec=date&amp;submit=Submit\">Antonio Scalfari<\/a><\/span><a class=\"xref-aff\" id=\"xref-aff-1-1\" href=\"http:\/\/jnnp.bmj.com\/content\/85\/1\/67.abstract#aff-1\">1<\/a>,<\/li>\n<li class=\"contributor\" id=\"contrib-2\"><span class=\"name\"><a class=\"name-search\" href=\"http:\/\/jnnp.bmj.com\/search?author1=Anneke+Neuhaus&amp;sortspec=date&amp;submit=Submit\">Anneke Neuhaus<\/a><\/span><a class=\"xref-aff\" id=\"xref-aff-2-1\" href=\"http:\/\/jnnp.bmj.com\/content\/85\/1\/67.abstract#aff-2\">2<\/a>,<\/li>\n<li class=\"contributor\" id=\"contrib-3\"><span class=\"name\"><a class=\"name-search\" href=\"http:\/\/jnnp.bmj.com\/search?author1=Martin+Daumer&amp;sortspec=date&amp;submit=Submit\">Martin Daumer<\/a><\/span><a class=\"xref-aff\" id=\"xref-aff-2-2\" href=\"http:\/\/jnnp.bmj.com\/content\/85\/1\/67.abstract#aff-2\">2<\/a>,<\/li>\n<li class=\"contributor\" id=\"contrib-4\"><span class=\"name\"><a class=\"name-search\" href=\"http:\/\/jnnp.bmj.com\/search?author1=Paolo+Antonio+Muraro&amp;sortspec=date&amp;submit=Submit\">Paolo Antonio Muraro<\/a><\/span><a class=\"xref-aff\" id=\"xref-aff-1-2\" href=\"http:\/\/jnnp.bmj.com\/content\/85\/1\/67.abstract#aff-1\">1<\/a>,<\/li>\n<li class=\"last\" id=\"contrib-5\"><span class=\"name\"><a class=\"name-search\" href=\"http:\/\/jnnp.bmj.com\/search?author1=George+Cornell+Ebers&amp;sortspec=date&amp;submit=Submit\">George Cornell Ebers<\/a><\/span><a class=\"xref-aff\" id=\"xref-aff-3-1\" href=\"http:\/\/jnnp.bmj.com\/content\/85\/1\/67.abstract#aff-3\">3<\/a><\/li>\n<\/ol>\n<p>&nbsp;<!--TrendMD v2.4.8--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The holy grail of MS therpay is to prevent the onset of the debilitating MS phase.\u00a0 All of the current therpaies are aimed at preventing such developments, and more importantly early treatment with immunomodulatory therapies was shown to be more efficacious at preventing disability development.\u00a0\u00a0 The issue of whether multiple relapses or &#8220;attacks&#8221; govern diability [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/blogs.bmj.com\/jnnp\/2014\/04\/07\/factors-governing-progression-in-ms-something-old-something-frequent\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"author":160,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-359","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Factors governing progression in MS: Something old, something frequent! - JNNP blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/jnnp\/2014\/04\/07\/factors-governing-progression-in-ms-something-old-something-frequent\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Factors governing progression in MS: Something old, something frequent! - JNNP blog\" \/>\n<meta property=\"og:description\" content=\"The holy grail of MS therpay is to prevent the onset of the debilitating MS phase.\u00a0 All of the current therpaies are aimed at preventing such developments, and more importantly early treatment with immunomodulatory therapies was shown to be more efficacious at preventing disability development.\u00a0\u00a0 The issue of whether multiple relapses or &#8220;attacks&#8221; govern diability [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/jnnp\/2014\/04\/07\/factors-governing-progression-in-ms-something-old-something-frequent\/\" \/>\n<meta property=\"og:site_name\" content=\"JNNP blog\" \/>\n<meta property=\"article:published_time\" content=\"2014-04-07T07:09:31+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/jnnp.bmj.com\/publisher\/icons\/toc\/pc-cyan.gif\" \/>\n<meta name=\"author\" content=\"Steve Vucic, Web Editor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Steve Vucic, Web Editor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/2014\\\/04\\\/07\\\/factors-governing-progression-in-ms-something-old-something-frequent\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/2014\\\/04\\\/07\\\/factors-governing-progression-in-ms-something-old-something-frequent\\\/\"},\"author\":{\"name\":\"Steve Vucic, Web Editor\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/#\\\/schema\\\/person\\\/5b9f797a427758da9d63182166e6458c\"},\"headline\":\"Factors governing progression in MS: Something old, something frequent!\",\"datePublished\":\"2014-04-07T07:09:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/2014\\\/04\\\/07\\\/factors-governing-progression-in-ms-something-old-something-frequent\\\/\"},\"wordCount\":207,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/2014\\\/04\\\/07\\\/factors-governing-progression-in-ms-something-old-something-frequent\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/jnnp.bmj.com\\\/publisher\\\/icons\\\/toc\\\/pc-cyan.gif\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/2014\\\/04\\\/07\\\/factors-governing-progression-in-ms-something-old-something-frequent\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/2014\\\/04\\\/07\\\/factors-governing-progression-in-ms-something-old-something-frequent\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/2014\\\/04\\\/07\\\/factors-governing-progression-in-ms-something-old-something-frequent\\\/\",\"name\":\"Factors governing progression in MS: Something old, something frequent! - JNNP blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/2014\\\/04\\\/07\\\/factors-governing-progression-in-ms-something-old-something-frequent\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/2014\\\/04\\\/07\\\/factors-governing-progression-in-ms-something-old-something-frequent\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/jnnp.bmj.com\\\/publisher\\\/icons\\\/toc\\\/pc-cyan.gif\",\"datePublished\":\"2014-04-07T07:09:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/2014\\\/04\\\/07\\\/factors-governing-progression-in-ms-something-old-something-frequent\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/2014\\\/04\\\/07\\\/factors-governing-progression-in-ms-something-old-something-frequent\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/2014\\\/04\\\/07\\\/factors-governing-progression-in-ms-something-old-something-frequent\\\/#primaryimage\",\"url\":\"http:\\\/\\\/jnnp.bmj.com\\\/publisher\\\/icons\\\/toc\\\/pc-cyan.gif\",\"contentUrl\":\"http:\\\/\\\/jnnp.bmj.com\\\/publisher\\\/icons\\\/toc\\\/pc-cyan.gif\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/2014\\\/04\\\/07\\\/factors-governing-progression-in-ms-something-old-something-frequent\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Factors governing progression in MS: Something old, something frequent!\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/\",\"name\":\"JNNP blog\",\"description\":\"The official JNNP blog. A place to discuss wider neurology beyond the journal&#039;s monthly edition.\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/#organization\",\"name\":\"JNNP blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/files\\\/2017\\\/11\\\/blog-logo-jnnp1.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/files\\\/2017\\\/11\\\/blog-logo-jnnp1.png\",\"width\":427,\"height\":34,\"caption\":\"JNNP blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/#\\\/schema\\\/person\\\/5b9f797a427758da9d63182166e6458c\",\"name\":\"Steve Vucic, Web Editor\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8e68076dae6fcffc1703a9f57f705b2f6f05335487da4d73145fa337d10c9b5a?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8e68076dae6fcffc1703a9f57f705b2f6f05335487da4d73145fa337d10c9b5a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8e68076dae6fcffc1703a9f57f705b2f6f05335487da4d73145fa337d10c9b5a?s=96&d=mm&r=g\",\"caption\":\"Steve Vucic, Web Editor\"},\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jnnp\\\/author\\\/svucic\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Factors governing progression in MS: Something old, something frequent! - JNNP blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/jnnp\/2014\/04\/07\/factors-governing-progression-in-ms-something-old-something-frequent\/","og_locale":"en_US","og_type":"article","og_title":"Factors governing progression in MS: Something old, something frequent! - JNNP blog","og_description":"The holy grail of MS therpay is to prevent the onset of the debilitating MS phase.\u00a0 All of the current therpaies are aimed at preventing such developments, and more importantly early treatment with immunomodulatory therapies was shown to be more efficacious at preventing disability development.\u00a0\u00a0 The issue of whether multiple relapses or &#8220;attacks&#8221; govern diability [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/jnnp\/2014\/04\/07\/factors-governing-progression-in-ms-something-old-something-frequent\/","og_site_name":"JNNP blog","article_published_time":"2014-04-07T07:09:31+00:00","og_image":[{"url":"http:\/\/jnnp.bmj.com\/publisher\/icons\/toc\/pc-cyan.gif","type":"","width":"","height":""}],"author":"Steve Vucic, Web Editor","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Steve Vucic, Web Editor","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/jnnp\/2014\/04\/07\/factors-governing-progression-in-ms-something-old-something-frequent\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jnnp\/2014\/04\/07\/factors-governing-progression-in-ms-something-old-something-frequent\/"},"author":{"name":"Steve Vucic, Web Editor","@id":"https:\/\/blogs.bmj.com\/jnnp\/#\/schema\/person\/5b9f797a427758da9d63182166e6458c"},"headline":"Factors governing progression in MS: Something old, something frequent!","datePublished":"2014-04-07T07:09:31+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/jnnp\/2014\/04\/07\/factors-governing-progression-in-ms-something-old-something-frequent\/"},"wordCount":207,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/jnnp\/#organization"},"image":{"@id":"https:\/\/blogs.bmj.com\/jnnp\/2014\/04\/07\/factors-governing-progression-in-ms-something-old-something-frequent\/#primaryimage"},"thumbnailUrl":"http:\/\/jnnp.bmj.com\/publisher\/icons\/toc\/pc-cyan.gif","inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/jnnp\/2014\/04\/07\/factors-governing-progression-in-ms-something-old-something-frequent\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/jnnp\/2014\/04\/07\/factors-governing-progression-in-ms-something-old-something-frequent\/","url":"https:\/\/blogs.bmj.com\/jnnp\/2014\/04\/07\/factors-governing-progression-in-ms-something-old-something-frequent\/","name":"Factors governing progression in MS: Something old, something frequent! - JNNP blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jnnp\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blogs.bmj.com\/jnnp\/2014\/04\/07\/factors-governing-progression-in-ms-something-old-something-frequent\/#primaryimage"},"image":{"@id":"https:\/\/blogs.bmj.com\/jnnp\/2014\/04\/07\/factors-governing-progression-in-ms-something-old-something-frequent\/#primaryimage"},"thumbnailUrl":"http:\/\/jnnp.bmj.com\/publisher\/icons\/toc\/pc-cyan.gif","datePublished":"2014-04-07T07:09:31+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/jnnp\/2014\/04\/07\/factors-governing-progression-in-ms-something-old-something-frequent\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/jnnp\/2014\/04\/07\/factors-governing-progression-in-ms-something-old-something-frequent\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jnnp\/2014\/04\/07\/factors-governing-progression-in-ms-something-old-something-frequent\/#primaryimage","url":"http:\/\/jnnp.bmj.com\/publisher\/icons\/toc\/pc-cyan.gif","contentUrl":"http:\/\/jnnp.bmj.com\/publisher\/icons\/toc\/pc-cyan.gif"},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/jnnp\/2014\/04\/07\/factors-governing-progression-in-ms-something-old-something-frequent\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/jnnp\/"},{"@type":"ListItem","position":2,"name":"Factors governing progression in MS: Something old, something frequent!"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/jnnp\/#website","url":"https:\/\/blogs.bmj.com\/jnnp\/","name":"JNNP blog","description":"The official JNNP blog. A place to discuss wider neurology beyond the journal&#039;s monthly edition.","publisher":{"@id":"https:\/\/blogs.bmj.com\/jnnp\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/jnnp\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/jnnp\/#organization","name":"JNNP blog","url":"https:\/\/blogs.bmj.com\/jnnp\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jnnp\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/jnnp\/files\/2017\/11\/blog-logo-jnnp1.png","contentUrl":"https:\/\/blogs.bmj.com\/jnnp\/files\/2017\/11\/blog-logo-jnnp1.png","width":427,"height":34,"caption":"JNNP blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/jnnp\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/jnnp\/#\/schema\/person\/5b9f797a427758da9d63182166e6458c","name":"Steve Vucic, Web Editor","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/8e68076dae6fcffc1703a9f57f705b2f6f05335487da4d73145fa337d10c9b5a?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8e68076dae6fcffc1703a9f57f705b2f6f05335487da4d73145fa337d10c9b5a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8e68076dae6fcffc1703a9f57f705b2f6f05335487da4d73145fa337d10c9b5a?s=96&d=mm&r=g","caption":"Steve Vucic, Web Editor"},"url":"https:\/\/blogs.bmj.com\/jnnp\/author\/svucic\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/posts\/359","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/users\/160"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/comments?post=359"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/posts\/359\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/media?parent=359"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/categories?post=359"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jnnp\/wp-json\/wp\/v2\/tags?post=359"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}